Menu
Back to Journals » OncoTargets and Therapy » Volume 13
Original Research
Anlotinib as Exploratory Therapy for Platinum-Resistant Ovarian Cancer: A Retrospective Study on Efficacy and Safety
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,882 | Dovepress* | 4,249+ | 769 | 5,018 | |
| PubMed Central* | 633 | 214 | 847 | ||
| Totals | 4,882 | 983 | 5,865 | ||
| *Since 5 October 2020 | |||||
View citations on PubMed Central and Google Scholar